TAT 48-57

TAT 48-57 is a synthetic peptide fragment derived from the trans-activator of transcription (TAT) protein of the human immunodeficiency virus type 1 (HIV-1). Comprising amino acids 48 to 57 of the full-length TAT protein, this peptide is renowned for its potent cell-penetrating properties, which enable it to traverse cellular membranes efficiently. Its unique sequence, rich in basic residues, facilitates cellular uptake through mechanisms such as macropinocytosis and direct translocation, making it a valuable tool in molecular and cellular biology research. The functional significance of TAT 48-57 lies in its widespread use as a delivery vector for various molecular cargos, including proteins, nucleic acids, and nanoparticles, thereby advancing experimental strategies in intracellular delivery and molecular targeting studies.

Cell Penetrating Peptide Research: TAT 48-57 serves as a prototypical cell-penetrating peptide (CPP) in experimental investigations aimed at understanding the mechanisms of membrane translocation. Researchers utilize this peptide to dissect the structural features and physicochemical properties that govern efficient cellular uptake. Its well-characterized sequence provides a robust model for comparative studies with other CPPs, helping elucidate the determinants of cellular internalization, endosomal escape, and intracellular trafficking. These insights are instrumental in the rational design of next-generation molecular delivery systems.

Intracellular Delivery Applications: The peptide is extensively employed as a carrier for the intracellular transport of diverse molecular entities, including proteins, peptides, oligonucleotides, and small-molecule drugs. By covalently or non-covalently conjugating experimental payloads to TAT 48-57, researchers can overcome the permeability barrier posed by the plasma membrane, thereby enhancing the efficiency of intracellular delivery. This approach is particularly valuable in studies requiring the manipulation of intracellular targets, such as gene regulation, protein-protein interaction mapping, and functional genomics.

Peptide-Drug Conjugate Development: In the context of drug delivery research, TAT 48-57 is frequently incorporated into peptide-drug conjugates to facilitate targeted transport across cellular membranes. Its use enables the evaluation of novel therapeutic strategies in preclinical models, supporting the development of advanced delivery platforms for bioactive compounds. By leveraging its cell-penetrating capabilities, scientists can assess the intracellular bioavailability and activity of candidate molecules, accelerating the optimization of delivery vectors for research use.

Bioconjugation and Labeling Studies: The peptide's compatibility with various chemical modification strategies makes it a versatile scaffold for bioconjugation and labeling experiments. Researchers often attach fluorescent tags, affinity ligands, or other reporter groups to TAT 48-57 to visualize and quantify cellular uptake, subcellular localization, and trafficking dynamics. These studies provide critical data on the efficiency and specificity of peptide-mediated delivery pathways, informing the design of functionalized biomolecules for advanced imaging and analytical applications.

Functional Proteomics and Cellular Assays: TAT 48-57 is routinely utilized in functional proteomics and cellular assay development, where efficient intracellular access is required for assay components or modulators. By facilitating the direct delivery of bioactive peptides, proteins, or inhibitors into living cells, it enables the interrogation of complex biological processes under physiologically relevant conditions. Such applications are integral to high-content screening, pathway analysis, and the validation of molecular targets in cell-based research, underscoring the peptide's importance in contemporary biochemical and cell biology workflows.

1. Store-operated Ca2+ entry sustains the fertilization Ca2+ signal in pig eggs

2. Immune responses to peptides containing homocitrulline or citrulline in the DR4-transgenic mouse model of rheumatoid arthritis

3. An Isolated TCR αβ Restricted by HLA-A* 02: 01/CT37 Peptide Redirecting CD8+ T Cells to Kill and Secrete IFN-γ in Response to Lung Adenocarcinoma Cell Lines

4. Peptides as Active Ingredients: A Challenge for Cosmeceutical Industry

5. Emu oil in combination with other active ingredients for treating skin imperfections